Neuroendoscopy Market Report 2026

Neuroendoscopy Market Overview

• Neuroendoscopy market size has reached to $0.78 billion in 2025 • Expected to grow to $1.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: Rising Brain Tumor Cases Fueling Growth Of The Market Due To Increasing Demand for Minimally Invasive Neurosurgical Solutions • Market Trend: Revolutionizing Spinal Surgery With Advanced Biportal Endoscopic Techniques • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neuroendoscopy Market?

Neuroendoscopy is a minimally invasive surgical technique used to diagnose and treat neurological disorders, including brain tumors, epilepsy, and cerebrovascular conditions. It utilizes specialized endoscopic tools inserted through small incisions, offering a less invasive alternative to traditional surgeries. The primary goal is to provide precise treatment with minimal disruption to surrounding tissues, leading to quicker recovery times, reduced infection risks, and lower healthcare costs. This technique enhances surgical accuracy, improves patient outcomes, and supports the growing preference for minimally invasive procedures in neurosurgery. The main products in neuroendoscopy are rigid neuroendoscopes, rigid fiberscopes, rigid videoscopes, and flexible neuroendoscopes. Rigid neuroendoscopes are straight, non-flexible instruments commonly used in brain surgeries, offering high-resolution imaging through a lens system that enables surgeons to clearly visualize internal brain structures. This is utilized for both adult and pediatric patients, with key applications including tumor removal and endoscopic third ventriculostomy (ETV). These procedures are typically performed by various end users such as hospitals, clinics, clinical laboratories, and others.

What Is The Neuroendoscopy Market Growth Forecast?

The neuroendoscopy market size is expected to see strong growth in the next few years. It will grow to $1.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive brain surgeries, rising investments in advanced surgical imaging, expansion of pediatric neurosurgery services, growing focus on faster patient recovery, continuous innovation in neuroendoscopic instruments. Major trends in the forecast period include increasing adoption of minimally invasive neuroendoscopic procedures, rising use of hd and 4k visualization systems, growing demand for flexible neuroendoscopes, expansion of pediatric neuroendoscopy applications, enhanced focus on surgical precision and safety.

What Is The Driver Of The Neuroendoscopy Market?

The increasing cases of brain tumors are expected to propel the growth of the neuroendoscopy market going forward. Brain tumors are abnormal growths of cells within the brain or central spinal canal, which can be malignant or benign. They can affect brain function and may require surgical, radiological, or medical intervention depending on their type and location. Improved diagnostic imaging combined with rising exposure to environmental risk factors such as ionizing radiation and industrial pollutants has contributed to the reported increase in brain tumor cases. Neuroendoscopy helps treat brain tumors by allowing minimally invasive access to the brain, enabling tumor removal or biopsy with reduced trauma, faster recovery, and fewer complications. For instance, in 2023, according to the Cancer Australia, an Australia-based government agency, reported that an estimated 1,924 new cases of brain cancer were diagnosed in the country, including 1,183 males and 741 females, accounting for 1.2% of all new cancer cases. Therefore, the rising incidence of brain tumors is driving the growth of neuroendoscopy industry.

Key Players In The Global Neuroendoscopy Market

Major companies operating in the neuroendoscopy market are Medtronic plc, Stryker Corporation, Karl Storz SE & Co. KG, Carl Zeiss Meditec AG, Aesculap AG, B. Braun Melsungen AG, Richard Wolf GmbH, Integra LifeSciences Holdings Corporation, Schindler Endoskopie Technologie GmbH, Machida Endoscope Co. Ltd., Adeor Medical AG, Inova Technology GmbH, Zhejiang Tiansong Medical Instrument Co. Ltd., Tonglu WANHE Medical Instrument Co. Ltd., Olympus Corporation, Fujifilm Holdings Corporation, ConMed Corporation, Schoelly Fiberoptic GmbH, Endoservice GmbH, Ackermann Instrumente GmbH, XION Medical GmbH, Happersberger Otopront GmbH

Global Neuroendoscopy Market Trends and Insights

Major companies operating in the neuroendoscopy market are focusing on advancements such as biportal endoscopic surgical system, to enhance surgical precision, reduce invasiveness, improve patient recovery times, and expand the range of treatable neurological conditions. A biportal endoscopic system enables minimally invasive surgery by using two entry points: one for viewing and one for operating, allowing for clearer imaging, more precise procedures, and faster recovery. For instance, in October 2023, Joimax, a US-based surgical sytem manufacturing company, launched he iLESSYS biportable endoscopic system for spinal surgery, offering enhanced freedom of movement and precision through biportal access. Featuring tools for triangulation, irrigation control, and tissue resection, it enables both biportal and bimanual techniques.

What Are Latest Mergers And Acquisitions In The Neuroendoscopy Market?

In August 2024, KARL STORZ, a Germany-based medical technology company, acquired Asensus Surgical Inc. for an undisclosed amount. This acquisition boosts its robotic surgery capabilities, enabling the delivery of advanced, AI-driven minimally invasive solutions that enhance surgical precision and patient outcomes. Asensus Surgical Inc. is a US-based surgical technology company specializes in providing digital surgical solutions.

What Defines the Neuroendoscopy Market?

The neuroendoscopy market consists of revenues earned by entities providing services such as minimally invasive neurosurgeries, diagnostic imaging, patient care, and post-operative recovery solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuroendoscopy market also includes sales of advanced endoscopic equipment, surgical tools, diagnostic imaging systems, and specialized surgical instruments used in neurosurgery. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neuroendoscopy Market Report 2026?

The neuroendoscopy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neuroendoscopy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.